October 27, 2020
FDA drafting protocols to track COVID-19 vaccine safety
Editor's Note
The Food and Drug Administration’s (FDA’s) Office of Biostatistics and Epidemiology is currently developing master protocols to be used in monitoring the safety and effectiveness of a COVID-19 vaccine once it is authorized or approved, in addition to postmarket surveillance requirements, the October 22 Regulatory Focus reports.
The FDA will draw on big data resources and the Centers for Disease Control and Prevention to follow the vaccines’ track records.
The protocols will be posted for public comment.
Free Daily News
- Study: Adenotonsillectomy reduces healthcare use in children with mild sleep-disordered breathing
- Introducing New Leader Toolkit: Your guide to OR leadership success
- Northwestern tests autonomous blood draw robot
- Unplanned hospital admissions post ASC visits remain exceptionally low, study finds
- Cardiology efficiency, orthopedic revenue surge as ASCs navigate growing complexity
- Study: BMI, hidden tumors complicate intubation
- New 7T MRI technique pinpoints hidden epilepsy-causing brain lesions
- Wildfires linked to longer postop hospital stay following lung cancer surgery, study finds
- Smart t-shirt enables earlier discharge, safer recovery after urological cancer surgery
- Study compares robotic, laparoscopic cholecystectomy cost drivers
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement